Skip to main content

Pfizer's Covid drug Paxlovid may reduce the risk of developing long Covid, study says

People who took Pfizer's antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn't, the study said.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.